Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

In Vitro Diagnostics - Global Market Outlook (2015-2022)

Stratistics Market Research Consulting
Posted on: 23 Sep 16

According to Stratistics MRC, the Global In Vitro Diagnostics market is accounted for $61.65 billion in 2015 and is expected to reach $94.57 billion by 2022 growing at a CAGR of 6.3%. Technologically advanced healthcare and consumer spending in market is helping the market growth. Polluted environment and contaminated surroundings are leading to increase in number of chronic disease and infections, these all factors are favoring the market to grow. Moreover widely spread knowledge and cost effectiveness are also driving the market. But stringent regulations and reimbursement issues are hampering the market growth.

However Infectious disease in application segment is anticipated to grow at considerable pace due to rise in amount of infectious diseases and it is followed by HIV/AIDS application. Whereas Laboratories in end-user segment is estimated to grow fast because of rise in number of laboratories, followed by Point of Care Diagnostics. North America being the largest revenue market, Asia Pacific is expected to grow fast due to increasing number of End-User applications.

Some of the major key players in the market are Roche Diagnostics  Bio-Rad Laboratories, Inc., Johnson and Johnson , Biomérieux, Siemens Healthcare, Abbott Laboratories, Inc., Thermo Fisher Scientific, Inc., Ortho Clinical Diagnostics, Inc., Danaher Corporation, Sysmex Corporation, Becton, Dickinson and Company, Cepheid Inc , Alere Inc., Novartis and Leica Biosystems. 

Applications Covered:
• Diabetes
• Autoimmune Diseases
• Cardiology
• Drug Testing
• Infectious Diseases
• Nephrology
• Oncology/Cancer
• Other Applications

Product & Services Covered:
• Data Management Software/Hardware
• Instruments
• Reagents & Kits
• Services

Technologies Covered:
• Immunochemistry/Immunoassays  
o Elisa
§ Chemiluminescence Immunoassays (CLIAs)
§ Colorimetric Immunoassays (CI)
§ Fluorescence Immunoassays (FIA)
o Western Blot
o Rapid Tests
o Radioimmunoassay’s (RIA)
o Elispot
• Coagulation and Hemostasis  
• Molecular Diagnostics (MDX)  
o DNA Sequencing & Next-Generation Sequencing
o Hybridization
o Isothermal Nucleic Acid Amplification Technology (INAAT)
o Microarrays
o Polymerase Chain Reaction (PCR)
o Other Molecular Diagnostics
• Hematology  
• Microbiology  
• Clinical Chemistry  
o Electrolyte Panels
o Basic Metabolic Panel
o Lipid Profiles
o Liver Panels
o Renal Profiles
o Specialty Chemical Tests
o Thyroid Function Panels
• Other Technologies 

End-Users Covered:
• Academic Institutes
• Hospitals
• Laboratories
• Patient Self-Testing
• Point-Of-Care Testing
• Other End-Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain     
o Rest of Europe 
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific      
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

For more information:

Editor's Details

James Lamb
Research and Marketing

Last updated on: 23/09/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.